| CENTER ID: | KloxA.20485.a |
| ORGANISM: | Klebsiella oxytoca CAV1374 |
| ASSOCIATED DISEASE: | |
| CURRENT STATUS: | purified |
| COMMUNITY REQUEST: | False |
| NIH RISK GROUP: | 2 |
| SELECT AGENT: | False |
| NIH PRIORITY pathogens category: |
unclassified |
| CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
|---|---|---|---|---|---|
| KloxA.20485.a.B1.PW39257 | Full length(KloxA.20485.a) | 1 | 283 |
| RESOURCE | REFERENCE ID |
|---|---|
| BV-BRC: | fig|571.323.peg.1321 |
| UniProt: | A0A318FX57 |
| PURIFICATION DATe: | 1/30/2024 |
| CONCENTRATION: | 15.8mg/ml |
| OBSERVED MW: | 33kDa |
| EXPRESSION LEVEL: | High Expression |
| PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
| EXPRESSION HOST: | BL 21 (DE3) Rosetta |
| VIAL COUNT (approx.): | 42 |
| VIAL VOLUME: | 200µl |
| PERCENT IDENTITY: | 95 |
| PERCENT COVERAGE: | 100 |